While the PALB2 expression-cutoff for haplosufficiency is unknown, we previously showed that variants expressing ≥ 30% of the ATM full-length transcript cannot be classified as pathogenic [16] or, in other words, these variants would keep their tumor-suppressor activity. The gene discussed is PALB2; the disease is neoplasm.